Biostar Pharmaceuticals Inc. vs China Pharma Holdings Inc.
A side-by-side look at two Chinese stocks — live quote, valuation, growth, listing venue, dual-listing and delisting status, and the WealthyTec Rank. A factual comparison for orientation, not investment advice.
| Metric | Biostar Pharmaceuticals Inc. BSPM · US (ADR) 0.00 USD | China Pharma Holdings Inc. CPHI · US (ADR) 0.57 USD |
|---|---|---|
| Day change | 0.00% | -10.97% |
| Market cap | $266 | $24.8M |
| P/E (TTM) | — | — |
| 2y EPS CAGR | — | +8.9% |
| WealthyTec Rank | 0.6 | 2.0 |
| Rank within sector | #29 of 31 | #21 of 31 |
| Listing venue | NYSE / NASDAQ (ADR) | NYSE / NASDAQ (ADR) |
| Other listings | n/a | n/a |
| Delisting filings | None on record | None on record |
| Sector | Health Care | Health Care |
| Industry | Biotech and Pharma | Biotech and Pharma |
Of the two, China Pharma Holdings Inc. currently carries the higher WealthyTec Rank (2.0 vs 0.6). The Rank reflects past revenue, earnings and EPS trends only — not valuation, momentum, or the policy and delisting risks every China investor should weigh, and it is not a recommendation to buy, sell or hold either security. See our rank methodology.